Cedars-Sinai and Caltech Forge New Scientific Partnership

Cedars-Sinai Health Sciences University and Caltech have launched a new partnership to drive innovative collaborations and foster scientific breakthroughs beyond what either organization could achieve alone.

“This new academic alliance between these premier Los Angeles institutions will advance scientific and academic achievements for the broader Los Angeles community and beyond,” said Peter L. Slavin, MD, president and CEO of Cedars-Sinai Medical Center and Cedars-Sinai Health System.

The partnership features joint translational discovery grants, as well as co-hosted symposia, shared training opportunities, and joint student and faculty appointments.

“Our partnership with Cedars-Sinai provides an important new pathway to clinical impact,” said Caltech Provost David A. Tirrell, PhD, the Ross McCollum-William H. Corcoran Professor of Chemistry and Chemical Engineering and the Carl and Shirley Larson Provostial Chair.

Shlomo Melmed, MB, ChB, executive vice president of Medicine and Health Sciences and dean of the Medical Faculty at Cedars-Sinai, said the goal of the partnership is to reshape patient care and biological understanding, together.

“Recognizing the unique strengths of each institution, we feel confident this partnership will benefit the greater field of science,” Melmed said.

Cedars-Sinai Health Sciences University combines a robust basic, translational and clinical sciences enterprise with a large and diverse patient population, along with an expanding biospecimen repository. Caltech brings exceptional expertise in engineering, computational modeling, chemistry, and quantitative biosciences, along with advanced research in molecular, cellular and systems biology.

“Better healthcare for all requires bold innovation. This partnership brings together Cedars-Sinai’s clinical leadership and Caltech’s scientific excellence to deliver it,” said  Viviana Gradinaru, PhD, the Lois and Victor Troendle Professor of Neuroscience and Biological Engineering, Howard Hughes Medical Institute Investigator, and director and Allen V. C. Davis and Lenabelle Davis Leadership Chair of the Merkin Institute for Translational Research.

The official partnership has been years in the making, with investigators like Ueli Rutishauser, PhD, director of the Center for Neural Science and Medicine and professor of Neurosurgery, Neurology and Biomedical Sciences at Cedars-Sinai, holding faculty appointments at both institutions. Those joint faculty positions opened the door for thoughtful discussions on how the two entities could increase their collaborations.

Ophir Klein, MD, PhD, executive director of Cedars-Sinai Guerin Children’s, executive vice dean of Children’s Health and the David and Meredith Kaplan Distinguished Chair in Children’s Health, recognized the potential synergy when he joined Cedars-Sinai in 2022.  Klein then initiated co-hosted programs to foster greater collaboration.

The first joint symposium, in 2024, concentrated on developmental and stem cell biology. The second, in 2025, focused on computational and experimental neuroscience. Both events sparked enthusiasm and spurred the impetus for further collaborations.

“The opportunity to engage regularly through these events will lead to a more profound partnership between the two institutions and deeper connections among faculty and trainees,” Klein said. “There’s a unique energy in the room when two complementary forces have a shared desire for the best in science and accelerated application.”

Another element of the strengthened partnership involves a pilot grant program to catalyze research that unites clinical insight, engineering and fundamental biological discovery.

The joint grant program will award up to four recipients with support for a one-year project and an opportunity for a second year. Funds will be split between investigators at Cedars-Sinai and Caltech.

“We are eager to stimulate interdisciplinary collaborations that support research and integrate biomedical, clinical, computational and engineering approaches,” said Jeffrey A. Golden, MD, executive vice dean of Research and Education and director of the Burns and Allen Research Institute at Cedars-Sinai. “Leveraging the scientific and technological ecosystems of both institutions will help advance the broader research landscape and bring advances in healthcare to individuals in our community and beyond.”

Cedars-Sinai Health Sciences University is advancing groundbreaking research and educating future leaders in medicine, biomedical sciences and allied health sciences. Learn more about the university.